Verge Medical Acquires RoVo System from 2MG Medical

June 30, 2025

Verge Medical, a privately held medical technology company based in Campbell, California, acquired the RoVo System and its patented Temporary Occlusion Embolectomy (TOE) technology from 2MG Medical. The asset purchase (with FDA-cleared technology) expands Verge's portfolio of targeted vascular devices to address distal embolization risk during peripheral and coronary interventions.

Buyers
Verge Medical
Targets
RoVo System
Sellers
2MG Medical
Industry
Medical Devices
Location
United States
Transaction Type
Divestiture

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.